- 全部删除
您的购物车当前为空
O-2050 是一种高亲和力的大麻素CB1受体拮抗剂,Ki 为 2.5 nM。O-2050 抑制大麻素 CB2受体,Ki 为 0.2 nM。O-2050 减少了小鼠的食物摄入量,并且引起小鼠运动。

O-2050 是一种高亲和力的大麻素CB1受体拮抗剂,Ki 为 2.5 nM。O-2050 抑制大麻素 CB2受体,Ki 为 0.2 nM。O-2050 减少了小鼠的食物摄入量,并且引起小鼠运动。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 14,900 | 8-10周 | |
| 50 mg | ¥ 19,420 | 8-10周 | |
| 100 mg | ¥ 24,625 | 8-10周 |
O-2050 相关产品
| 产品描述 | O-2050 is a high affinity cannabinoid CB 1 receptor antagonist with a K i of 2.5 nM. O-2050 inhibits cannabinoid CB 2 receptor with Ki of 0.2 nM. O-2050 decreased food intake in mice and caused locomotor stimulation in mice [1]. |
| 靶点活性 | CB1:2.5 nM (Ki), CB2:0.2 nM (Ki) |
| 体内活性 | O-2050 (1, 3, 10, 30 mg/kg; ip; pretreatment 30 mins) produces significant and dose-dependent decreases in food intake in mice. O-2050 (10, 30 mg/kg) markedly causes locomotor stimulation [1]. |
| 分子量 | 417.56 |
| 分子式 | C23H31NO4S |
| CAS No. | 1883545-42-3 |
| 密度 | 1.173 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: <41.76 mg/mL, Sonication is recommended. Ethanol: <41.76 mg/mL, Sonication is recommended. |
评论内容